Circle Pharma Closes $90 Million Series D Financing to Advance ...

Sep 3, 2024 · SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable …

CouponFollow Extension

$90
OFF

Circle Pharma Closes $90 Million Series D Financing To Advance ...

1 week from now

Sep 3, 2024 · SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable …

circlepharma.com

$90
OFF

Circle Pharma Closes $90 Million Series D Financing To Advance ...

1 week from now

Sep 3, 2024 · Roslyn Patterson 650.825.4099 [email protected]. SOUTH SAN FRANCISCO, Calif., September 03, 2024--Circle Pharma, a clinical-stage biopharmaceutical …

yahoo.com

$90
OFF

Circle Pharma Closes $90 Million Series D Financing To Advance ...

1 week from now

Sep 3, 2024 · Circle Pharma Closes $90 Million Series D Financing to Advance Innovative Oral Macrocycle Therapies. Circle Pharma, a clinical-stage biopharmaceutical company dedicated …

morningstar.com

$90
OFF

Circle Pharma Closes $90 Million Series D Financing To Advance ...

1 week from now

Sep 3, 2024 · Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycles as a new class of therapies, today …

dnews.com

$90
OFF

Circle Pharma Closes $90 Million Series D Financing To Advance …

1 week from now

Sep 9, 2024 · Key Highlights. Circle Pharma raises $90 million in Series D funding led by The Column Group. Funding to support clinical trials of CID-078 and expand the company’s …

sliceofhealthcare.com

$90
OFF

Circle Pharma Closes $90 Million Series D Financing

1 week from now

September 03, 2024. SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell …

allianceofceos.com

$90
OFF

Circle Pharma Closes $90 Million Series D Financing To Advance ...

1 week from now

Sep 3, 2024 · Circle Pharma Closes $90 Million Series D Financing to Advance Innovative Oral Macrocycle Therapies. SOUTH SAN FRANCISCO, Calif.-- (BUSINESS WIRE)-- Circle …

streetinsider.com

$90
OFF

Wilson Sonsini Advises Circle Pharma On $90 Million Series D

1 week from now

Sep 12, 2024 · Client Highlights. September 12, 2024. On September 3, 2024, Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell …

wsgr.com

$90
OFF

Circle Pharma Raises $90M Series D Round - Vcnewsdaily.com

1 week from now

Sep 3, 2024 · Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycles as a new class of therapies, today …

vcnewsdaily.com

$90
OFF

Circle Pharma Closes $90 Million Series D Financing To Advance ...

1 week from now

Circle Pharma Closes $90 Million Series D Financing to Advance Innovative Oral Macrocycle Therapies

marketwatch.com

$90
OFF

Circle Pharma Closes $90 Million Series D Financing To Advance ...

1 week from now

Sep 3, 2024 · [#item_full_content]SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– #BreastCancerResearch–Circle Pharma, a clinical-stage biopharmaceutical company …

mbn.media

$90
OFF

Invest In Circle Pharma Stock | Buy Pre-IPO Shares - EquityZen

1 week from now

Circle Pharma Raises $90M Series D Round. vcnewsdaily • Sep 05, 2024. Circle Pharma Closes $90 Million Series D Financing to Advance Innovative Oral Macrocycle Therapies. …

equityzen.com

$90
OFF

Circle Pharma Closes $90 Million Series D Financing To Advance ...

1 week from now

On September 3, 2024 Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycles as a new class of therapies, reported …

1stoncology.com

$90
OFF

Circle Pharma Closes $90 Million Series D Financing To Advance ...

1 week from now

Sep 3, 2024 · SOUTH SAN FRANCISCO, Calif.– Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable …

blstimes.com

$90
OFF

Series D - Circle Pharma - 2024-09-03 - Crunchbase

1 week from now

Sep 3, 2024 · Business Wire — Circle Pharma Closes $90 Million Series D Financing to Advance Innovative Oral Macrocycle Therapies . News • Sep 3, 2024. Venture Capital Access Online — …

crunchbase.com

$90
OFF

Circle Pharma Closes $90 Million Series D Financing To Advance ...

1 week from now

Sep 3, 2024 · Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycles as a new class of therapies, today …

wedbush.com